What is the role of HbA1c (Hemoglobin A1c) in managing diabetes during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of HbA1c in Pregnancy

HbA1c should be used as a secondary measure of glycemic control in pregnancy, with self-monitoring of blood glucose (SMBG) remaining the primary tool for achieving optimal pre- and postprandial glucose targets. 1

Why HbA1c Has Limited Primary Utility in Pregnancy

Physiological Changes Affect HbA1c Interpretation

  • Red blood cell turnover increases during pregnancy, causing HbA1c levels to fall below non-pregnant values even in women with normal glucose metabolism 1
  • HbA1c represents an integrated average of glucose levels and does not adequately capture postprandial hyperglycemia, which is the primary driver of macrosomia and other fetal complications 1
  • Standard estimated A1C and glucose management indicator calculations should not be used in pregnancy as they are unreliable 1

Primary Role: SMBG Targets

Fasting and postprandial self-monitoring of blood glucose is the recommended primary method for achieving optimal glycemic control in both gestational diabetes mellitus (GDM) and preexisting diabetes 1

The glucose targets are:

  • Fasting plasma glucose <95 mg/dL (5.3 mmol/L) 1
  • 1-hour postprandial glucose <140 mg/dL (7.8 mmol/L) 1
  • 2-hour postprandial glucose <120 mg/dL (6.7 mmol/L) 1

When and How to Use HbA1c in Pregnancy

Preconception Period

Women planning pregnancy should achieve HbA1c <6.5% (<48 mmol/mol) before conception to reduce the risk of congenital anomalies, preeclampsia, macrosomia, and preterm birth 1

  • Observational studies demonstrate that HbA1c levels correlate directly with congenital malformations, particularly anencephaly, microcephaly, congenital heart disease, and renal anomalies occurring during the first 10 weeks of gestation 1, 2
  • The lowest rates of adverse fetal outcomes occur with preconception HbA1c <6.5% (<48 mmol/mol) 1

During Pregnancy

The optimal HbA1c target during pregnancy is <6% (<42 mmol/mol) if achievable without significant hypoglycemia, but may be relaxed to <7% (<53 mmol/mol) if necessary to prevent hypoglycemia 1

  • In the second and third trimesters, HbA1c <6% (<42 mmol/mol) has the lowest risk of large-for-gestational-age infants, preterm delivery, preeclampsia, and other complications 1
  • HbA1c should be monitored more frequently than usual (e.g., monthly) given the altered red blood cell kinetics and physiological changes in glycemic parameters during pregnancy 1

Important Caveats

  • The HbA1c goal must be achieved without hypoglycemia, which may increase the risk of low birth weight in addition to usual maternal adverse effects 1
  • For women with type 1 diabetes and history of recurrent hypoglycemia or hypoglycemia unawareness, less stringent targets may be necessary 1

Role of Continuous Glucose Monitoring (CGM)

When used in addition to pre- and postprandial SMBG, CGM can help achieve HbA1c targets and reduce adverse outcomes in pregnancies complicated by type 1 diabetes 1

  • The CONCEPTT trial demonstrated that real-time CGM in type 1 diabetes pregnancy improved HbA1c and time in range without increasing hypoglycemia, and reduced large-for-gestational-age births, neonatal hospital stays, and severe neonatal hypoglycemia 1
  • CGM metrics should be used as an adjunct but not as a substitute for SMBG to achieve optimal pre- and postprandial targets 1
  • CGM-reported mean glucose is superior to estimated A1C calculations for assessing glycemic control in pregnancy 1

HbA1c for Diagnosis in Pregnancy

HbA1c ≥6.5% (≥48 mmol/mol) can be used to diagnose preexisting diabetes in early pregnancy, but has significant limitations for detecting gestational diabetes 1

  • An early pregnancy HbA1c cutoff of 5.7% has been identified as optimal for detecting diabetes in pregnancy diagnosed by oral glucose tolerance test (OGTT), though sensitivity remains only 64.6% 3
  • HbA1c analysis is less useful than OGTT for detecting gestational diabetes in later pregnancy 4
  • Women with HbA1c ≥5.7% in early pregnancy have increased risks of requiring insulin, macrosomia, and shoulder dystocia 3

Postpartum Follow-up

HbA1c analysis postpartum detects fewer women with abnormal glucose tolerance than OGTT, but the ease of testing may improve follow-up rates 4

  • Combining HbA1c with fasting plasma glucose or waist circumference may improve detection rates of persistent glucose abnormalities postpartum 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.